Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities
  2. Parexel launches integrated FPS model to drive delivery of clinical research partnerships
  3. Medable unveils telemedicine solution only for clinical trials
  4. Broader inclusion criteria to double eligible cancer patients for clinical trials, finds study
  5. Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

Latest Content

October’s top news stories

GSK has initiated the Phase III EAGLE programme of gepotidacin for the treatment of uncomplicated urinary tract infection and urogenital gonorrhoea, and AstraZeneca has reported that a combination of Imfinzi with chemotherapy improved progression-free survival (PFS) in the ongoing Phase III POSEIDON trial in non-small cell lung cancer (NSCLC). Clinicaltrialsarena.comwraps up key headlines from October 2019.

Latest News

Close
Close
Close

Go Top